Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 109, 2001 - Issue 4
31
Views
11
CrossRef citations to date
0
Altmetric
Research Article

VIP and PACAP Enhance the In Vivo Generation of Memory TH2 Cells by Inhibiting Peripheral Deletion of Antigen-Specific Effectors

&
Pages 372-376 | Published online: 03 Oct 2008

References

  • Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH (1995): Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71–79.
  • Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL (1996): The significance of vasoactive intestinal peptide (VIP) in immunomodulation. Adv Neuroimmunol 6: 5–27.
  • Delgado M, Ganea D (2000): Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J Immunol 164: 1200–1210.
  • Delgado M, Leceta J, Gomariz RP, Ganea D (1999b): VIP and PACAP stimulate the induction of Th2 responses by up-regulating B7.2 expression. J Immunol 163: 3629–3635.
  • Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999c): VIP and PACAP inhibit IL-12 production in LPS-stimu-lated macrophages. Subsequent effect on IFNy synthesis by T Cells. J Neuroimmunol 96: 167–181.
  • Delgado M, Munoz-Elias EJ, Martinez C, Gomariz RP, Ganea D (1999a): Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP38) mod-ulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann NY Acad Sci 897: 401–415.
  • Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995): Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 348–441.
  • Ganea D (1996): Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv Neuroimmunol 6: 61–74.
  • Ganea D, Delgado M (2001): Inhibitory neuropeptide receptors on macrophages. Microbes and Infection 3: 141–147.
  • Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Shen DH, Stanger BZ, Marshak-Rothstein A (1995): Fas(CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373: 441 /18.
  • Lenardo MJ (1991): Interleukin-2 programs mouse alpha beta T lymphocytes for apopotosis. Nature 353: 858–861.
  • Lenardo MJ, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, Zheng L (1999): Mature T lymphocyte apoptosis: immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17: 221–253.
  • Nagata S, Golstein P (1995): The Fas death factor. Science 267: 1449–1456.
  • Pozo D, Delgado M, Martinez C, Leceta J, Gomariz RP, Guer-rero JM, Calvo JR (2000): Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today 21: 7–11.
  • Russell JH, White CL, Loh DY, Meleedy-Rey P (1991): Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 88: 2155–2163.
  • Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S (1995) Expression of the Fas ligand in cells of the T cell lineage. J Immunol 154: 3806–3813.
  • Swain SL (1994): Generation and in vivo persistence of polar-ized Thl and Th2 memory cells. Immunity 1: 543–552.
  • Wang HY, Jiang XM, Ganea D (2000): The neuropeptides VIP and PACAP inhibit IL2 transcription by decreasing c-Jun and increasing JunB expression in T cells. J Neuroimmunol 104: 68–78.
  • Zheng L, Trageser CL, Willerford DM, Lenardo MJ (1998): T cell growth cytokines cause the superinduction of mol-ecules mediating antigen-induced T lymphocyte death. J Immunol 160: 763–771.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.